Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

BACKGROUND: Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the cardiovascular implications of COVID-19. The goal herein, was to evaluate the prognostic impact of having heart disease (HD) and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cardiol J
Egile Nagusiak: Villalba, Gonzalo Cabezón, Amat-Santos, Ignacio J., Dueñas, Carlos, Otero, Diego López, Catalá, Pablo, Aparisi, Álvaro, López-Pais, Javier, Antonio, Carla Eugenia Cacho, Candela, Jordi, Muiños, Pablo Antúnez, Gil, José Francisco, Ferrero, Teba González, Marcos, Marta, Pérez-Poza, Marta, Rojas, Gino, García, Oscar Otero, Veras, Carlos, Ramos, Víctor Jiménez, Uribarri, Aitor, Revilla, Ana, García-Granja, Pablo Elpidio, Gómez, Itzíar, González-Juanatey, José Ramón, San Román, J. Alberto
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Via Medica 2021
Gaiak:
COVID-19
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8169179/
https://ncbi.nlm.nih.gov/pubmed/33843043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5603/CJ.a2021.0034
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak